Prohibiting the sale of dextromethorphan to minors
If enacted, HB 2481 would amend Chapter 94C of the Massachusetts General Laws to enforce regulations prohibiting minors from purchasing or attempting to purchase dextromethorphan. Retailers would be required to ensure that purchasers present valid photo identification to verify their age. The measure introduces civil penalties for violators, with escalating fines for repeat offenses. Additionally, the bill preempts any local laws regarding the sale of dextromethorphan, thereby centralizing regulatory authority at the state level.
House Bill 2481 proposes the prohibition of the sale of dextromethorphan, a common cough suppressant, to individuals under the age of 18. This bill aims to address health concerns associated with the misuse of this substance by minors, who may consume it recreationally for its psychoactive effects. By restricting access to this over-the-counter medication, the bill seeks to promote public health and safeguard youth from potential harm arising from misuse.
There may be points of contention surrounding the bill’s implementation and its impact on local governance. While supporters argue that the bill is necessary for safeguarding minors, critics might raise concerns about the efficacy of age restrictions in preventing substance misuse. Moreover, retailers could express concerns regarding the burdensome nature of verifying age without imposing additional compliance requirements, such as altering the placement of products in stores.